Allspring Global Investments
IMGO

Allspring Global Investments’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Allspring Global Investments’s Portfolio IMGO Stock Details IMGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,541
Closed -$68K – 3046
2022
Q1 		$68K Sell
3,541
-426
-11% -$8.84K ﹤0.01% 2808
2021
Q4 		$94K Buy
+3,967
New +$91.9K ﹤0.01% 2777

Other funds holding IMGO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Allspring Global Investments's IMGO Position: Q2 2022 in Review

Allspring Global Investments sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q2 2022, closing a stake of 3,541 shares — an estimated $68K sold.

Allspring Global Investments first reported a position in IMGO in Q4 2021 and held it in 2 quarters. The position peaked at $94K in Q4 2021. 62 funds tracked by Wall St. Rank hold IMGO as of Q2 2022.

  • Allspring Global Investments reported no remaining Imago BioSciences, Inc. Common stock position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 3,541 Imago BioSciences, Inc. Common stock shares in Q2 2022, an estimated $68K.
  • Allspring Global Investments first reported a position in Imago BioSciences, Inc. Common stock in Q4 2021 and held it in 2 quarters.
  • Allspring Global Investments's Imago BioSciences, Inc. Common stock position peaked at $94K in Q4 2021.
  • 62 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.